LAB
Standard BioTools, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.64
+2.27%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.45x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.30x
- Net debt / EBITDA
- 2.59x
Liquidity & coverage
- Current ratio
- 9.10x
- Quick ratio
- 8.80x
- Cash ratio
- 8.39x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $460.1M
Cash & dividend
- FCF / debt
- -2.94x
- Cash flow / debt
- -2.86x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026